(CNN) — President Donald Trump signed an executive order on Thursday aimed at expediting the reclassification of marijuana, a move intended to enhance research into its medical applications without fully legalizing the substance. “This reclassification order will make it far easier to conduct marijuana-related medical research, allowing us to study benefits, potential dangers, and future treatments,” Trump stated in the Oval Office, emphasizing its positive impact.
Significance for the Cannabis Industry
The directive compels Attorney General Pam Bondi to accelerate the process of relaxing federal restrictions on marijuana, although it does not provide a specific timeline. This decision follows significant lobbying from the cannabis sector, which is particularly relevant for states like Mississippi, where the industry is still evolving.
Currently classified as a Schedule I drug alongside heroin and LSD, marijuana is regarded by the Drug Enforcement Administration (DEA) as having no acceptable medical use. The anticipated reclassification to Schedule III suggests a recognition of its moderate potential for physical and psychological dependence, indicating a shift in federal acknowledgment of its medical benefits.
Implications for Policy and Research
Trump noted that the evidence supports the idea that marijuana can serve legitimate medical purposes when monitored carefully. He highlighted its potential as a substitute for addictive opioid painkillers, framing this development as a matter of “common sense.”
It is important to clarify that this order does not result in the federal legalization of marijuana. Despite its legality in several states, including Mississippi, the executive action does not address recreational use or make any modifications to criminal justice policies concerning cannabis.
The order also encourages White House aides to collaborate with Congress to ensure access to full-spectrum CBD products and instructs the Department of Health and Human Services to explore broader access to hemp-derived CBD items. This broader accessibility could present new opportunities for businesses involved in the cannabis market.
This is a developing story, and updates will follow as more information becomes available.
